[MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6]
- PMID: 32376567
- PMCID: PMC7040756
- DOI: 10.12122/j.issn.1673-4254.2020.01.10
[MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6]
Abstract
Objective: To investigate the role of microRNA-145-5p (miR-145-5p) in regulating the proliferation, migration, invasion and apoptosis of human endometrial carcinoma cells.
Methods: Human endometrial carcinoma Ishikawa cells were transfected with miR-145-5p mimic, miR-145-5p inhibitor, or their negative controls via liposome (Lipo2000), and the changes in the expression of miR-145-5p was verified by real-time PCR. The effects of overexpression or inhibition of miR-145-5p on the proliferation, migration, invasion and apoptosis of the cells were evaluated using MTT assay, wound healing assay, Transwell assay or flow cytometry. Bioinformatic analysis was performed to predict the target genes of miR-145-5p. The mRNA and protein expression levels of the downstream target of miR-145-5p, namely dual specific phosphatase 6 (DUSP6), were detected using real-time PCR and Western blotting.
Results: Transfection of the cells with miR-145-5p mimic significantly suppressed the proliferation of Ishikawa cells, while transfection with miR-145-5p inhibitor obvious enhanced the proliferation of the cells (P < 0.05). Over-expression of miR-145-5p significantly suppressed the migration and invasion and promoted apoptosis of the cells, and inhibition of miR-145-5p caused the reverse changes (P < 0.05). Bioinformatic analysis showed that DUSP6 was the potential target gene of miR-145-5p. Over-expression of miR-145-5p significantly lowered while inhibition of miR-145-5p significantly enhanced the expression of DUSP6 protein (P < 0.05).
Conclusions: Overexpression of miR-145-5p inhibits the proliferation, migration and invasion and promotes apoptosis of endometrial cancer cells possibly by negative regulation of DUSP6 expression.
目的: 探讨微小RNA-145-5p(miR-145-5p)靶向双特异性磷酸酶6(DUSP6)对于人子宫内膜癌Ishikawa细胞增殖、迁移、侵袭与凋亡能力的影响。
方法: 人子宫内膜癌Ishikawa细胞分为A组(未转染组)、B组(mimic NC组)、C组(mimic组)、D组(inhibitor NC组)、E组(inhibitor组),采用脂质体(Lipo 2000)细胞转染法转染。利用RT-PCR技术验证miR-145-5p的表达;过表达或抑制表达miR-145-5p对Ishikawa细胞增殖、迁移、侵袭及凋亡影响将运用MTT、伤口愈合、Transwell及凋亡实验检测;运用生物信息学方法预测miR-145-5p的潜在靶基因;运用RT-PCR及Western Blot技术检测细胞转染后下游靶基因DUSP6mRNA及蛋白的表达水平。
结果: 转染后48、72、96 h,C组比B组细胞增殖能力下降,E组比D组细胞的增殖能力增强,差异有统计学意义(P<0.05)。转染后24、48 h,C组比B组细胞迁移能力降低,E组比D组细胞迁移能力增强(P<0.05)。转染48 h后,C组比B组侵袭能力下降,E组比D组侵袭能力增强, 差异有统计学意义(P<0.05)。转染48 h后,A组、B组、C组、D组、E组凋亡率分别为(0.66±0.05)%、(0.60±0.03)%、(17.74±1.02)%、(0.72±0.04)%、(0.31±0.02)%,差异有统计学意义(P<0.05)。经生物信息学在线软件预测DUSP6是miR-145-5p的潜在靶基因。转染48 h后,DUSP6 mRNA在A组、B组、C组、D组、E组中的相对表达水平分别为1.00±0.09、1.09±0.08、0.47±0.04、1.03±0.05、4.62±0.26,差异有统计学意义(P<0.05)。其蛋白的相对表达量为0.29±0.03、0.28±0.04、0.16±0.03、0.32±0.05、0.74±0.05,差异有统计学意义(P<0.05)。
结论: miR-145-5p过表达后能够抑制子宫内膜癌细胞增殖、迁移、侵袭并且促进癌细胞凋亡,其机制可能是通过负向调节DUSP6的表达而实现。
Keywords: apoptosis; dual specific phosphatase 6; endometrial carcinoma; invasion; miR-145-5p; proliferation.
Figures





Similar articles
-
Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.Cancer Biother Radiopharm. 2019 Oct;34(8):529-536. doi: 10.1089/cbr.2018.2766. Epub 2019 Aug 19. Cancer Biother Radiopharm. 2019. PMID: 31424277
-
MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.Int J Mol Med. 2018 Mar;41(3):1740-1748. doi: 10.3892/ijmm.2018.3358. Epub 2018 Jan 2. Int J Mol Med. 2018. PMID: 29328362
-
MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.J Cell Biochem. 2018 Nov;119(10):8123-8137. doi: 10.1002/jcb.26763. Epub 2018 Jun 20. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S104. doi: 10.1002/jcb.30084. PMID: 29923214 Retracted.
-
MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.Cell Cycle. 2018;17(10):1268-1278. doi: 10.1080/15384101.2018.1475829. Epub 2018 Jul 23. Cell Cycle. 2018. Retraction in: Cell Cycle. 2021 Dec;20(24):2662. doi: 10.1080/15384101.2021.1971874. PMID: 29888640 Free PMC article. Retracted.
-
MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.Biomed Pharmacother. 2017 Aug;92:1038-1044. doi: 10.1016/j.biopha.2017.05.092. Epub 2017 Jun 10. Biomed Pharmacother. 2017. PMID: 28609841
Cited by
-
The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions.Front Endocrinol (Lausanne). 2023 Apr 21;14:1166948. doi: 10.3389/fendo.2023.1166948. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152960 Free PMC article. Review.
-
Non-Coding RNAs as Prognostic Markers for Endometrial Cancer.Int J Mol Sci. 2021 Mar 19;22(6):3151. doi: 10.3390/ijms22063151. Int J Mol Sci. 2021. PMID: 33808791 Free PMC article. Review.
-
Role of miRNA‑145‑5p in cancer (Review).Oncol Rep. 2025 Mar;53(3):39. doi: 10.3892/or.2025.8872. Epub 2025 Jan 31. Oncol Rep. 2025. PMID: 39886965 Free PMC article. Review.
References
-
- Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17(12):719–32. doi: 10.1038/nrg.2016.134. [Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer[J]. Nat Rev Genet, 2016, 17(12): 719-32.] - DOI - PubMed
-
- Zhi Y, Pan J, Shen W, et al. Ginkgolide B inhibits human bladder cancer cell migration and invasion through MicroRNA-223-3p. Cell Physiol Biochem. 2016;39(5):1787–94. doi: 10.1159/000447878. [Zhi Y, Pan J, Shen W, et al. Ginkgolide B inhibits human bladder cancer cell migration and invasion through MicroRNA-223-3p[J]. Cell Physiol Biochem, 2016, 39(5): 1787-94.] - DOI - PubMed
-
- Wen M, Kwon Y, Wang Y, et al. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. http://cn.bing.com/academic/profile?id=15047eb80ee2edf1bd01523838d3b10d&.... Oncotarget. 2015;6(28):25226–39. [Wen M, Kwon Y, Wang Y, et al. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer[J]. Oncotarget, 2015, 6(28): 25226-39.] - PMC - PubMed
-
- Yu H, Xiang P, Pan Q, et al. Ubiquitin-conjugating enzyme E2T is an Independent prognostic factor and promotes gastric cancer progression. Tumour Biol. 2016;37(9):11723–32. doi: 10.1007/s13277-016-5020-3. [Yu H, Xiang P, Pan Q, et al. Ubiquitin-conjugating enzyme E2T is an Independent prognostic factor and promotes gastric cancer progression[J]. Tumour Biol, 2016, 37(9): 11723-32.] - DOI - PubMed
-
- Xiang W, Han L, Mo G, et al. MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma. J Cell Biochem. 2020;121(2):1504–13. doi: 10.1002/jcb.29385. [Xiang W, Han L, Mo G, et al. MicroRNA-96 is a potential tumor repressor by inhibiting NPTX2 in renal cell carcinoma[J]. J Cell Biochem, 2020, 121(2): 1504-13.] - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous